CSL's Se­qirus flu vac­cine cam­paign keeps ‘twindem­ic’ dan­ger of Covid-19 and sea­son­al flu on front burn­er

Is there a twindem­ic de­ja vu in the works? Al­though last year’s dou­ble wham­my of Covid-19 and flu in­fec­tions nev­er panned out, CSL’s Se­qirus wants to make sure it doesn’t hap­pen this year, es­pe­cial­ly as flu cas­es are al­ready on the rise.

As pan­dem­ic re­stric­tions re­lax – more in­door mee­tups and trav­el and less mask wear­ing – the po­ten­tial for a re­al twindem­ic is cer­tain­ly pos­si­ble. While re­ports of in­fluen­za are still low­er than nor­mal, cas­es are ramp­ing up, ac­cord­ing to the CDC’s Flu­view mon­i­tor­ing sys­tem. The in­crease is hap­pen­ing, how­ev­er, even as three in five peo­ple in the US say they plan to skip or de­lay a flu vac­cine this sea­son.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER